Clinical Trial Update: YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering [Phase 2]

View source ↗

Summary

Phase 2 trial update on aggressive lipid lowering showing reduction in coronary yellow plaque, lipids, and vascular inflammation in obstructive coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Obstructive Coronary Artery Disease

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Obstructive Coronary Artery Disease, Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-02-13